China Pharma Holdings, Inc. Announces Record 2007 Year E...(105573 87612 Net Cash from ...)

Net Cash from Operating Activities 2,801,898 (1,736,333)

Cash Flows from Investing Activities:

Purchase of property and equipment (51,841) (182,346)

Proceeds from the sale of intangibles 1,509,741 --

Purchase of intangible assets (2,937,431) (9,657)

Net Cash from Investing Activities (1,479,531) (192,003)

Cash Flows from Financing Activities:

Proceeds from sale of common stock and

warrants 3,797,183 --

Proceeds from exercise of warrants 119,000 --

Proceeds from short term notes payable 2,586,252 2,140,943

Payments of short term notes payable (6,705,456) --

Proceeds from loan from shareholder -- 22,650

Payment of offering costs -- (58,167)

Net Cash Proceeds from Financing

Activities (203,021) 2,105,426

Effect of Exchange Rate Changes on

Cash 54,548 18,131

Net Change in Cash 1,173,894 195,221

Cash and Cash Equivalents at Beginning

of Period 656,441 461,220

Cash and Cash Equivalents at End of

Period $ 1,830,335 $ 656,441

Supplemental Cash Flow Disclosure:

Cash paid for interest $ 160,250 $ 87,690

Cash paid for income taxes -- 851,335

For more information, please contact:

China Pharma Holdings, Inc.

Sophia Yu

Tel: +86-898-6681-1730

Email: